Opus Genetics, Inc. (IRD) Form 8-K — Oct 21, 2026
Opus Genetics (IRD) disclosed that Ashwath Jayagopal is departing his role as Chief Scientific and Development Officer, effective October 19, 2026. Dr. Jayagopal signed a separation and release agreement that includes a six-month consulting arrangement at $250 per hour to provide transition services as requested by the company. His outstanding vested options remain exercisable during the consulting term.
Key figures
- Separation date
- 2026-10-19
- Consulting term months
- 6
- Consulting rate per hour
- 250
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.